However, no difference in the eNAMPT and proinflammatory marker (including HS-CRP and ALT) levels was found among CHC patients with various rs61330082 genotypes, and the rs61330082 T allele had a positive dose effect on the pre-therapy TC level as mentioned above. This evidence concerns the gene GPT and cryohydrocytosis.